ArticleScientific reports2016

MiR-101 Targets the EZH2/Wnt/β-Catenin the Pathway to Promote the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Hongrui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.